S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
Log in

NASDAQ:CCXIChemoCentryx Earnings Date, Estimates & History

$58.60
+2.03 (+3.59 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$55.74
Now: $58.60
$59.07
50-Day Range
$53.79
MA: $59.67
$65.07
52-Week Range
$6.16
Now: $58.60
$65.43
Volume852,506 shs
Average Volume700,355 shs
Market Capitalization$3.62 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.04

Earnings

ChemoCentryx (NASDAQ:CCXI) Earnings Information

ChemoCentryx last released its earnings data on May 11th, 2020. The biopharmaceutical company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.05. The business had revenue of $6.01 million for the quarter, compared to analysts' expectations of $8.90 million. ChemoCentryx has generated ($0.98) earnings per share over the last year. ChemoCentryx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 3rd, 2020 based off prior year's report dates.

ChemoCentryx Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ChemoCentryx (NASDAQ:CCXI) Earnings Estimates

2020 EPS Consensus Estimate: ($1.39)
2021 EPS Consensus Estimate: ($0.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.32)($0.30)($0.31)
Q2 20203($0.35)($0.31)($0.33)
Q3 20203($0.40)($0.30)($0.36)
Q4 20203($0.45)($0.33)($0.39)
Q1 20212($0.33)($0.27)($0.30)
Q2 20212($0.29)($0.24)($0.27)
Q3 20212($0.23)($0.18)($0.21)
Q4 20211($0.13)($0.13)($0.13)

ChemoCentryx (NASDAQ CCXI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/3/2020
(Estimated)
       
5/11/20203/31/2020($0.30)($0.35)($0.35)$8.90 million$6.01 millionTranscript
3/10/202012/31/2019($0.26)($0.26)($0.26)$9.42 million$10.05 millionTranscript
11/4/2019Q3($0.28)($0.22)($0.22)$7.83 million$10.58 millionTranscript
8/5/2019Q2 2019($0.21)($0.26)($0.26)$10.08 million$7.17 millionTranscript
5/6/20193/31/2019($0.24)($0.23)($0.23)$11.37 million$8.33 millionTranscript
3/11/201912/31/2018($0.27)($0.21)($0.21)$9.54 million$9.33 millionTranscript
11/8/2018Q3($0.25)($0.22)($0.22)$11.55 million$8.98 millionTranscript
8/9/2018Q2 2018($0.15)($0.14)($0.14)$16.88 million$15.02 millionN/A
5/9/2018Q1 2018($0.23)($0.19)($0.19)$9.10 million$9.55 millionN/A
3/9/2018Q4 2017($0.22)$0.80$0.80$9.03 million$56.30 millionTranscript
11/7/2017Q3 2017($0.26)($0.13)($0.13)$8.94 million$9.03 millionN/A
8/8/2017Q2 2017($0.17)($0.19)($0.19)$8.94 millionListen
5/10/2017Q1 2017($0.2550)($0.12)($0.12)$8.23 millionN/A
3/14/2017Q4 2016($0.22)($0.16)($0.16)$4.89 millionN/A
11/7/2016Q3($0.08)($0.15)($0.15)$4.25 millionListen
8/8/2016Q2 2016$0.07($0.22)($0.22)$2.80 millionN/A
5/10/2016Q1($0.27)($0.34)($0.34)Listen
3/14/2016Q4($0.28)($0.26)($0.26)N/A
11/9/2015Q315($0.29)($0.26)($0.26)Listen
8/6/2015Q215($0.29)($0.28)($0.28)N/A
5/6/2015Q115($0.28)($0.28)($0.28)Listen
3/12/2015Q414($0.28)($0.28)($0.28)Listen
11/5/2014Q3 2014($0.29)($0.25)($0.25)N/A
8/5/2014Q2 2014($0.27)($0.28)($0.28)N/A
5/8/2014Q114($0.24)($0.27)($0.27)$0.38 millionN/A
3/13/2014Q4 2013($0.24)($0.22)($0.22)$1.37 million$0.73 millionN/A
11/7/2013Q3 2013($0.26)($0.22)($0.22)$1.97 million$1.52 millionN/A
8/12/2013Q2 2013($0.29)($0.23)($0.23)$1.48 million$1.90 millionN/A
5/13/2013Q1 2013($0.27)($0.28)($0.28)$2.04 million$1.90 millionTranscript
3/13/2013Q4 2012($0.29)($0.28)($0.28)N/A
11/13/2012Q312($0.28)$1.44 million$1.13 millionTranscript
8/10/2012Q2 2012($0.19)($0.30)($0.30)N/A
5/10/2012Q1 2012($0.20)($0.28)($0.28)N/A
3/30/2012Q4 2011$0.44$0.61$0.61N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.